These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38961380)

  • 1. Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification.
    Aguilan JT; Lim J; Racine-Brzostek S; Fischer J; Silvescu C; Cornett S; Nieves E; Mendu DR; Aliste CM; Semple S; Angeletti R; Weiss LM; Cole A; Prystowsky M; Pullman J; Sidoli S
    Clin Proteomics; 2024 Jul; 21(1):47. PubMed ID: 38961380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
    Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
    Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis.
    Winter M; Tholey A; Kristen A; Röcken C
    Proteomics; 2017 Nov; 17(22):. PubMed ID: 28994248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
    Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
    Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
    Lim A; Prokaeva T; McComb ME; O'Connor PB; Théberge R; Connors LH; Skinner M; Costello CE
    Anal Chem; 2002 Feb; 74(4):741-51. PubMed ID: 11866053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
    Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
    Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies.
    Bindi G; Smith A; Oliveira G; Eccher A; Vatrano S; Alberici F; Cazzaniga G; Galimberti S; Capitoli G; Magni F; Pagni F; L'Imperio V
    J Clin Pathol; 2024 May; 77(6):402-410. PubMed ID: 36813560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Compact Quadrupole-Orbitrap Mass Spectrometer with FAIMS Interface Improves Proteome Coverage in Short LC Gradients.
    Bekker-Jensen DB; Martínez-Val A; Steigerwald S; Rüther P; Fort KL; Arrey TN; Harder A; Makarov A; Olsen JV
    Mol Cell Proteomics; 2020 Apr; 19(4):716-729. PubMed ID: 32051234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALDI mass spectrometry imaging unravels organ and amyloid-type specific peptide signatures in pulmonary and gastrointestinal amyloidosis.
    Schürmann J; Gottwald J; Rottenaicher G; Tholey A; Röcken C
    Proteomics Clin Appl; 2021 Nov; 15(6):e2000079. PubMed ID: 34061454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
    Lavatelli F; Merlini G
    Proteomics; 2018 Apr; 18(7):e1700353. PubMed ID: 29389069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits.
    Abildgaard N; Rojek AM; Møller HE; Palstrøm NB; Nyvold CG; Rasmussen LM; Hansen CT; Beck HC; Marcussen N
    Amyloid; 2020 Mar; 27(1):59-66. PubMed ID: 31752543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis.
    Sethi S; Theis JD; Leung N; Dispenzieri A; Nasr SH; Fidler ME; Cornell LD; Gamez JD; Vrana JA; Dogan A
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2180-7. PubMed ID: 20876678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autopsy case with concurrent transthyretin and immunoglobulin amyloidosis.
    Shintani-Domoto Y; Ishino K; Naiki H; Sakatani T; Ohashi R
    Pathol Int; 2022 Jan; 72(1):65-71. PubMed ID: 34637570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI imaging directed laser ablation tissue microsampling for data independent acquisition proteomics.
    Wang K; Donnarumma F; Pettit ME; Szot CW; Solouki T; Murray KK
    J Mass Spectrom; 2020 Apr; 55(4):e4475. PubMed ID: 31726477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.
    Aoki M; Kang D; Katayama A; Kuwahara N; Nagasaka S; Endo Y; Terasaki M; Kunugi S; Terasaki Y; Shimizu A
    Clin Exp Nephrol; 2018 Aug; 22(4):871-880. PubMed ID: 29372474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced mass spectrometry workflows for accurate quantification of trace-level host cell proteins in drug products: Benefits of FAIMS separation and gas-phase fractionation DIA.
    Beaumal C; Beck A; Hernandez-Alba O; Carapito C
    Proteomics; 2023 Aug; 23(16):e2300172. PubMed ID: 37148167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
    Adachi M; Kitamura M; Muta K; Maekawa A; Uramatsu T; Tadokoro M; Funakoshi S; Hisano S; Kuwahara N; Shimizu A; Mukae H; Nishino T
    BMC Nephrol; 2020 May; 21(1):195. PubMed ID: 32448180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.